AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25308231
Drug: VK1 tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VK1 tablets
Trial: 20483024
Drug: Minimally invasive
RxNorm normalized name: SPY Minimally Invasive Surgery (SPY-MIS) Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimally invasive treatment group
Trial: 20483024
Drug: Medical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical treatment group
Trial: 18587731
Drug: Once-weekly intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly intravenous epoetin alfa
Trial: 18587731
Drug: Conventional dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional dosing of intravenous epoetin alfa or darbepoetin
Trial: 11835638
Drug: Aspirin monotherapy
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin monotherapy after Carbostent implantation
Trial: 11835638
Drug: Combined ticlopidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined ticlopidine and aspirin (future comparison group)
Trial: 7770254
Drug: Low-dose aspirin
RxNorm normalized name: low-dose aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose aspirin (less than 200 mg/day)
Trial: 23512912
Drug: Metreleptin (physiological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metreleptin (physiological doses)
Trial: 17511770
Drug: Baclofen 10
RxNorm normalized name: baclofen 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baclofen 10 mg three times daily for 4 weeks
Trial: 15271125
Drug: Cardiovascular drugs
RxNorm normalized name: sodium chloride
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cardiovascular drugs
Trial: 15271125
Drug: Hormones
RxNorm normalized name: Other hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormones
Trial: 15271125
Drug: Nonopioid analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonopioid analgesics (predominantly NSAIDs and acetaminophen)
Trial: 15271125
Drug: Number of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Number of scheduled medications
Trial: 11878715
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of calcium channel blockers and ASA
Trial: 11878715
Drug: Diuretics and
RxNorm normalized name: Low-ceiling diuretics and potassium-sparing agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diuretics and ASA
Trial: 9514531
Drug: Amlodipine (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5-10 mg daily for 1 year)
Trial: 24716675
Drug: Treatment outcome
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment outcome
Trial: 17631948
Drug: Cangrelor IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cangrelor IV bolus (30 microg/kg) and a 2-hour infusion (4 microg/kg/min) with 600 mg clopidogrel loading dose
Trial: 17631948
Drug: Cangrelor bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cangrelor bolus and a 1-hour infusion with 600 mg clopidogrel loading dose
Trial: 16777855
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 or 400 mg/day
Trial: 16777855
Drug: Sustained-release paracetamol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release paracetamol 1330 mg three times a day
Trial: 14983653
Drug: Budesonide (1
RxNorm normalized name: budesonide (11.beta.,16.alpha.(S))
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (1 mg/2 ml) diluted with 2 ml isotonic sodium chloride
Trial: 14983653
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium chloride (4 ml)
Trial: 14983653
Drug: Terbutaline (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terbutaline (5 mg/2 ml) diluted with 2 ml isotonic sodium chloride
Trial: 14983653
Drug: Budesonide (1
RxNorm normalized name: budesonide (11.beta.,16.alpha.(S))
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (1 mg/2 ml) and terbutaline (5 mg/2 ml)
Trial: 10741293
Drug: Menstruation status
RxNorm normalized name: Statuss Green Reformulated Jan 2012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menstruation status after chemotherapy
Trial: 9083827
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of 6 mg heroin hydrochloride
Trial: 9083827
Drug: Intranasal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal administration of 12 mg heroin hydrochloride
Trial: 9083827
Drug: Intramuscular administration
RxNorm normalized name: Japanese Encephalitis vaccine for intramuscular administration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular administration of 6 mg heroin hydrochloride
Trial: 8366922
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy (external insulin pump or three or more daily insulin injections with frequent blood glucose monitoring)
Trial: 8366922
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (one or two daily insulin injections)
Trial: 3780290
Drug: ergoloid mesylates
RxNorm normalized name: Ergoloid Mesylates
DrugBank: Ergoloid mesylate (DB01049)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ergoloid mesylates (1.5 mg 3-times daily)
Trial: 31624333
Drug: Creatine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine treatment
Trial: 22820908
Drug: ilaprazole (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ilaprazole (5 mg)
Trial: 22820908
Drug: triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: triple therapy (ilaprazole 5 mg, clarithromycin 500 mg, amoxicillin 1 g)
Trial: 20523253
Drug: diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diazepam 10 mg plus clonidine 0.15 mg
Trial: 20523253
Drug: midazolam plus
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: midazolam plus clonidine 0.15 mg
Trial: 18477263
Drug: EXU 3
RxNorm normalized name: DRESSING,EXU-DRY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EXU 3 mg with no passive smoke exposure
Trial: 18477263
Drug: EXU 3
RxNorm normalized name: DRESSING,EXU-DRY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EXU 3 mg after passive smoke exposure (atmospheric nicotine levels 75-125 mug m(‐3) for 2 h)
Trial: 10858488
Drug: lovastatin (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lovastatin (20-40 mg/day, titrated to achieve LDL-cholesterol target of < or =110 mg/dL)
Trial: 1320987
Drug: Inhaled nedocromil
RxNorm normalized name: nedocromil Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nedocromil 4 mg q.i.d. for 8 weeks
Trial: 31365799
Drug: Immediate transfusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate transfusion with 20 ml or 30 ml of whole-blood equivalent per kilogram of body weight
Trial: 24700254
Drug: Placebo aerosol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo aerosol spray
Trial: 23138167
Drug: Cetuximab 500
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab 500 mg/m2 every 2 weeks (Group A)
Trial: 23138167
Drug: Cetuximab 750
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Cetuximab 750 mg/m2 every 2 weeks (Group B)
Trial: 20363366
Drug: Certolizumab pegol
RxNorm normalized name: Certolizumab Pegol
DrugBank: Certolizumab pegol (DB08904)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Certolizumab pegol reinduction (400 mg at weeks 0, 2, and 4)
Trial: 11948381
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone 400 microg/d
Trial: 11948381
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone 800 microg/d
Trial: 9465753
Drug: 10% pentastarch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% pentastarch solution (PS)
Trial: 9465753
Drug: Isotonic 0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic 0.9% NaCl solution (IS)
Trial: 2664372
Drug: FAMTX protocol
RxNorm normalized name: Olay Professional Acne Protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FAMTX protocol (high dose methotrexate and 5-fluorouracil combined with adriamycin)
Trial: 31151306
Drug: IBD98-M 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IBD98-M 0.8 g/day
Trial: 31151306
Drug: IBD98-M 1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IBD98-M 1.2 g/day
Trial: 10392645
Drug: Qualified physiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Qualified physiotherapy (QPT) - additional treatment from a qualified physiotherapist
Trial: 10392645
Drug: Assistant physiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assistant physiotherapy (APT) - additional treatment from a trained supervised assistant
Trial: 10392645
Drug: Additional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional treatment (QPT and APT)
Trial: 8675249
Drug: Nifedipine plus
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine plus diltiazem (180 mg/d)
Trial: 8675249
Drug: Nifedipine plus
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine plus verapamil (180 mg/d)
Trial: 8675249
Drug: Nifedipine alone
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine alone (30 mg/d)
Trial: 26329382
Drug: Modafinil (MOD)
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil (MOD) 200 mg daily for 4 weeks
Trial: 2139791
Drug: Gel form
RxNorm normalized name: Timoptic-XE 0.5 % Gel Forming Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gel form etchant
Trial: 22381043
Drug: Ritonavir (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritonavir (300 mg twice daily for 3 days)
Trial: 20461335
Drug: Standardized task‐oriented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized task‐oriented therapy with botulinum toxin injections
Trial: 20461335
Drug: Standardized task‐oriented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized task‐oriented therapy without botulinum toxin injections
Trial: 15608311
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of DMARDs with prednisolone
Trial: 2078483
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy with cyclophosphamide, methotrexate, 5‐fluorouracil, and low‐dose prednisone (CMFp)
Trial: 380909
Drug: Trimipramine (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimipramine (75 mg per day)
Trial: 31282037
Drug: Anesthetic cream
RxNorm normalized name: DIBUCAINE/DIPERODON ANESTHETIC CREAM
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anesthetic cream applied after cryotherapy treatment
Trial: 31282037
Drug: Cryotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cryotherapy treatment without anesthetic cream
Trial: 17541571
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg oral M6G
Trial: 17541571
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral M6G
Trial: 17541571
Drug: Paracetamol and
RxNorm normalized name: Paracetamol and tramadol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol and sulfasalazine coadministered with M6G
Trial: 15579192
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine oestrogens (CEE) 0.625 mg daily + Desogestrel (DG) 75 microg
Trial: 15579192
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine oestrogens (CEE) 0.625 mg daily + Medroxyprogesterone (MP) 10 mg
Trial: 15579192
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine oestrogens (CEE) 0.625 mg daily + Norethisterone (NE) 1 mg
Trial: 10526897
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine oestrogens (CEE) 0.625 mg daily
Trial: 9757170
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/d, increased to 100 mg/d if uncontrolled after 6 weeks
Trial: 9757170
Drug: Losartan 50
RxNorm normalized name: LOSARTAN 50MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 50 mg/d + Hydrochlorothiazide 12.5 mg/d if uncontrolled after 6 weeks
Trial: 9757170
Drug: Amlodipine 5
RxNorm normalized name: amlodipine 5 MG
DrugBank: Amlodipine (DB00381)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amlodipine 5 mg/d, increased to 10 mg/d if uncontrolled after 6 weeks
Trial: 30275398
Drug: Nutritional supplementation
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplementation combined with cognitive stimulation (fortified milk powder and daily learning activities)
Trial: 23142798
Drug: Withania somnifera
RxNorm normalized name: WITHANIA SOMNIFERA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Withania somnifera (2 g every 8 hours during chemotherapy)
Trial: 21620782
Drug: Target inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target inhalation mode (TIM)
Trial: 18464021
Drug: Estetrol 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estetrol 0.1 mg
Trial: 18464021
Drug: Estetrol 1
RxNorm normalized name: estetrol 14.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estetrol 1 mg
Trial: 18464021
Drug: Estetrol 10
RxNorm normalized name: estetrol
DrugBank: Estetrol (DB12235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Estetrol 10 mg
Trial: 18464021
Drug: Estetrol 100
RxNorm normalized name: estetrol
DrugBank: Estetrol (DB12235)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Estetrol 100 mg
Trial: 9210746
Drug: Monthly maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly maintenance interpersonal psychotherapy with placebo (N = 19)
Trial: 9210746
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and supportive medication clinic without interpersonal psychotherapy (N = 28)
Trial: 9210746
Drug: Medication clinic
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication clinic without interpersonal psychotherapy (N = 12)
Trial: 3297482
Drug: Neo Sampoon
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neo Sampoon vaginal tablets (60 mg menfegol)
Trial: 31086947
Drug: Escherichia coli-produced
RxNorm normalized name: escherichia coli
DrugBank: Escherichia coli (DB16539)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escherichia coli-produced bivalent HPV-16/18 vaccine
Trial: 25618966
Drug: Dendritic cells
RxNorm normalized name: Dendritic cells vaccine
DrugBank: Dendritic cells vaccine (DB15803)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dendritic cells (DCs) plus ginseng polysaccharides (GPS) administered thoracoscopically, once a week, 4 times for 30 days.
Trial: 20453655
Drug: Terlipressin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (2 mg bolus injection)
Trial: 16652085
Drug: Oral prednisone
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral prednisone for 2 weeks followed by intranasal budesonide for 12 weeks (Group A, n = 63)
Trial: 16652085
Drug: No steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No steroid treatment (Group B, n = 21)
Trial: 12651643
Drug: Liberalized fasting
RxNorm normalized name: Fast Freeze
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberalized fasting (Group L): formula fasted for 4-6 hours before surgery
Trial: 12651643
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (L and T)
Trial: 10092561
Drug: Regular weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular weekly aerobic training programme, three times a week for 12 months
Trial: 971031
Drug: Methylphenidate/thioridazine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate/thioridazine combination
Trial: 30885839
Drug: Intravenous dexamethasone
RxNorm normalized name: Dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous dexamethasone (Group A)
Trial: 30885839
Drug: Oral dexamethasone
RxNorm normalized name: dexamethasone Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dexamethasone (Group C)
Trial: 26964161
Drug: Fire needle
RxNorm normalized name: Fire Out
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fire needle treatment
Trial: 19519910
Drug: Enteral Nutrition
RxNorm normalized name: ENTERAL NUTRITION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral Nutrition combined with Parenteral Nutrition (EN + PN)
Trial: 15124680
Drug: Rituximab combined
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab combined with chemotherapy
Trial: 11269475
Drug: Individualized heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Individualized heparin dose calculated by an in vitro heparin dose‐response test (group HC)
Trial: 11269475
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of heparin (300 IU/kg; group C)
Trial: 9886723
Drug: Candoxatril (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candoxatril (100 mg twice daily)
Trial: 8290176
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogen (0.625 mg) (N = 28)
Trial: 3569737
Drug: Omeprazole 10
RxNorm normalized name: omeprazole 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 10 mg/d (Om10)
Trial: 3569737
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg/d (Om20)
Trial: 30032884
Drug: Nebulised midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nebulised midazolam 0.2 mg kg‐1 (Group M)
Trial: 30032884
Drug: Nebulised dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised dexmedetomidine 2 μg kg‐1 (Group D)
Trial: 30032884
Drug: Nebulised ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised ketamine 2 mg kg‐1 (Group K)
Trial: 20360183
Drug: Topical NSAID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical NSAID
Trial: 20360183
Drug: Oral NSAID
RxNorm normalized name: Ansaid Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral NSAID
Trial: 8978585
Drug: ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron 8 mg i.v. plus dexamethasone 20 mg i.v.
Trial: 8978585
Drug: metoclopramide 60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metoclopramide 60 mg i.v. plus dexamethasone 20 mg i.v.
Trial: 25632615
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol (400 microg, two hours prior to MVA)
Trial: 25632615
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (400 microg, two hours prior to MVA)
Trial: 25632615
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Sublingual and Oral)
Trial: 21277628
Drug: 20 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 μg ZEA/kg bw for 48 days
Trial: 21277628
Drug: 40 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 μg ZEA/kg bw for 48 days
Trial: 19217817
Drug: Strength training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strength training (twice weekly for 15 weeks followed by 24 weeks of unsupervised training)
Trial: 14693613
Drug: Ropivacaine 0.5%
RxNorm normalized name: ROPivacaine 0.5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.5% 200 mg/40 mL infiltrated at the wound site and continuous infusion of ropivacaine 0.2% at 5 mL/h for 55 hours
Trial: 14693613
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion at the same rate as the R group